Trials / Completed
CompletedNCT02284113
A Randomized, Study to Evaluate the Iovera° Device in Treating Pain Associated With Total Knee Arthroplasty
A Post-Market, Multi-Center, Prospective, Double-Blind, Randomized, Controlled Study to Evaluate the Iovera° Device in Treating Pain Associated With Total Knee Arthroplasty
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 150 (actual)
- Sponsor
- Pacira Pharmaceuticals, Inc · Industry
- Sex
- All
- Age
- 22 Years – 79 Years
- Healthy volunteers
- Accepted
Summary
This study will evaluate the iovera° device in treating pain associated with total knee arthroplasty (TKA). This study will also assess if overall pain medication is reduced following TKA and will investigate the relationship between patients treated with the iovera° device and length of hospital stay, pain, patient satisfaction and improved rehabilitation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | iovera° | Use of iovera° device to administer treatment Focused Cold Therapy |
| DEVICE | iovera° Sham | iovera° device used for sham treatment |
Timeline
- Start date
- 2014-12-01
- Primary completion
- 2016-05-01
- Completion
- 2016-06-01
- First posted
- 2014-11-05
- Last updated
- 2024-01-24
- Results posted
- 2023-07-27
Locations
8 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02284113. Inclusion in this directory is not an endorsement.